Critical Reviews in Therapeutic Drug Carrier Systems
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 42.7% | 0.469 | Q2 | 58.6% |
| 2024 | 2.5 | Q3 | 49.0% | 0.574 | Q2 | 67.0% |
| 2023 | 3.0 | Q2 | 62.5% | 0.536 | Q2 | 67.2% |
| 2022 | 2.7 | Q3 | 47.1% | 0.420 | Q2 | 60.8% |
| 2021 | 3.1 | Q3 | 51.6% | 0.473 | Q2 | 65.4% |
| 2020 | — | — | 0.730 | Q2 | 77.3% | |
| 2019 | — | — | 0.639 | Q1 | 74.4% | |
| 2018 | — | — | 0.736 | Q1 | 76.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2162-660X
ISSN
0743-4863
country
UScoverage
1984-2026